Steps Required to Prep for Fill Finish Clinical Trial Material

 

For drug manufacturers working on injectable medication, getting a new molecule to the clinic effectively and quickly is crucial; however, getting there with a safe product supply is also essential. Filling batches of clinical trial material is an important step in this process. Attention to a few major areas of this crucial pharmaceutical fill finish project can help prepare it for success.

Filling Clinical Trial Material

Before now, drug manufacturers spent quality time developing their molecules in a laboratory, manufacturing small volumes. In this phase of nurturing, the center is on understanding the molecule. However, two challenges are significant when it comes to in-human trial: developing a highly scalable, quality filling process that meets all quality and safety requirements and manufacturing significantly larger volumes to support a trial for in-human use.

The Four Steps Involved

Below are the four steps required in the preparation of medicine fill finish for clinical trial material;

1. Structuring a Proactive Plan

It takes time to successfully complete a first clinical batch project; it also takes more material than required just for clinical trials. It is recommended to always begin by setting up a schedule that permits all the extra steps that need to be taken and then make plans for a batch size that houses additional testing and analysis.

2. Organizing the Product

This is the perfect time to inform your CDMO partners and regulators more about the molecule, as this would help to ensure that it is ready for release to their test participants and clinical trials. Before your batch and IND are filed, crucial extra tests are needed to assess the stability, safety, and behavior outside the lab of the product.

 
3. Seeking the Right Expertise

Next, you want to start thinking about where and how you will find the multidisciplinary skills you require to excellently advance and execute your project; this includes process development, regulatory/CMC, project management, analytics, quality control/assurance, aseptic filling, and more.

You may want to procure CDMO partners and/or consultants like AbbVie contract manufacturing that can satisfy all the essential roles.

Employing the Best Practices

Fill finish clinical trial materials are usually the first time a new molecule is needed to be manufactured in a way that is in line with cGMPs, the nonstop growing standards that help ensure drug products are safe for use in humans.
Conclusion

To be in line with the aforementioned best practices, your production process will require a quality system that incorporates three critical workflows.

* Qualification of the personnel and equipment which will be in charge of the product

* Endorsement of the processes that are used to fill it

* Documentation of all steps to regulatory standards

If you can partner with the best CDMO, they can play an invaluable role in helping you build that system.

We encourage you to focus on the above steps, and we trust that your team will be able to get your clinical batch project to an excellent beginning and make room for essential future milestones.

For your drug fill finish solution, contact us today.